Cystic Fibrosis Expanded Screen - CFvantage

The Cystic Fibrosis Expanded Screen - CFvantage test contains 1 test with 5 biomarkers.

The CFvantage® Cystic Fibrosis Expanded Screen analyzes 155 mutations that have been proven to cause Cystic Fibrosis. This panel includes the 23 mutations recommended by the American College of Obstetricians and Gynecologists (ACOG) for screening of all child bearing age women. ACOG also recommends that patients with a family history of Cystic Fibrosis, pregnant women with ultrasound finding that indicate an increased risk of Cystic Fibrosis (echogenic bowel or dilated loops of the bowl), and males with a family history of infertility should be offered this screen.

  • No Prescription Needed
  • Discounts up to 80%
  • Hundreds of Lab Tests Available

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: CFVANTAGE CYSTIC FIBROSIS EXPANDED SCR

ADDITIONAL INFORMATION

CF RESULT

ETHNICITY:

INTERPRETATION

MUTATIONS ANALYZED

Search by Zip Code

No Results Found

There are no results that match the search criteria submitted.
Please change the criteria and try again.